MktsMarkets

X4 Pharmaceuticals, Inc.
NASDAQ: XFORKey statistics
XFOR News
Stories mentioning XFOR from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 2,708 | 2,568 | 1,765 | 1,973 | 28,807 | 560.00 | 563.00 | |
| Cost of Goods Sold | 598.00 | 364.00 | 351.00 | 326.00 | 4,716 | 227.00 | 268.00 | |
| Gross Profit | 2,110 | 2,204 | 1,414 | 1,647 | 24,091 | 0.00 | 333.00 | 295.00 |
| Operating Expenses | ||||||||
| Research & Development | 15,450 | 18,521 | 17,337 | 18,352 | 18,513 | 19,173 | 20,914 | |
| Sales General & Admin | ||||||||
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (20,306) | (23,699) | (27,509) | (26,232) | (9,443) | (34,500) | 71,103 | |
| Interest Income | 2,105 | 1,985 | 901.00 | 665.00 | 1,025 | 1,871 | 1,565 | |
| Interest Expense | 2,414 | 2,176 | ||||||
| Other Expense | 14.00 | (7.00) | (304.00) | (547.00) | 105.00 | 700.00 | 226.00 | 144.00 |
| Pretax Income | (20,241) | (23,925) | (29,845) | (25,704) | 316.00 | (39,563) | (36,681) | 90,851 |
| Tax Provision | 0.00 | 0.00 | (30.00) | 37.00 | 34.00 | 258.00 | 15.00 | 18.00 |
| Net Income (Loss) | (20,241) | (23,925) | (29,815) | (25,741) | 282.00 | (39,821) | (36,696) | 90,833 |
| Earnings Per Share (Basic) | (0.16) | (0.57) | (0.69) | (3.47) | 0.04 | (5.94) | (5.48) | 13.59 |
| Earnings Per Share (Diluted) | (0.16) | (0.57) | (0.69) | (3.47) | 0.04 | (5.94) | (5.48) | 13.57 |
| Weighted Average Shares Outstanding (Basic) | 126,289 | 42,293 | 43,273 | 7,413 | 6,840 | 6,702 | 6,696 | 6,681 |
| Weighted Average Shares Outstanding (Diluted) | 126,289 | 42,293 | 43,273 | 7,413 | 6,869 | 6,702 | 6,696 | 6,693 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About XFOR
X4 Pharmaceuticals, Inc. (NASDAQ: XFOR) is a stock listed on the Nasdaq Stock Market under the ticker symbol XFOR. It last traded at $2.83 (Nov 16, 2026, 4:00 PM ET), down 9.3% on the day. That gives X4 Pharmaceuticals a market capitalisation of $313.2M.
Over the past 52 weeks XFOR has traded between $2.43 and $4.83.
Revenue for the quarter ended Mar 31, 2026 was $2.7M; a net loss of $20.2M. Revenue was down 90.6% from $28.8M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $2.7M | -$20.2M | -747.5% |
| Dec 31, 2025 | $2.6M | -$23.9M | -931.7% |
| Sep 30, 2025 | $1.8M | -$29.8M | -1689.2% |
| Jun 30, 2025 | $2.0M | -$25.7M | -1304.7% |
From X4 Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…